ロード中...
Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies
BACKGROUND: Alzheimer’s disease (AD) could be regarded as a brain form of diabetes since insulin resistance and deficiency develop early and progress with severity of neurodegeneration. Preserving insulin’s actions in the brain restores function and reduces neurodegeneration. T3D-959 is a dual nucle...
保存先:
| 出版年: | J Alzheimers Dis Parkinsonism |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979550/ https://ncbi.nlm.nih.gov/pubmed/27525190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2161-0460.1000238 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|